Show of Hands

Martin Shkreli, a pharmaceutical CEO with rights to lifesaving HIV medication Daraprim, has maintained his 5000% markup on the drug, citing the relatively low price elasticity of demand. Do you believe that such a practice is ethical?

I do I don't

4 Liked